Edition:
United Kingdom

People: Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

35.80USD
14 Dec 2018
Change (% chg)

$-1.18 (-3.19%)
Prev Close
$36.98
Open
$36.60
Day's High
$36.60
Day's Low
$35.54
Volume
1,887,429
Avg. Vol
1,718,726
52-wk High
$39.43
52-wk Low
$24.79

Dockendorff, Charles 

Mr. Charles J. Dockendorff is Independent Director of the Company. Mr. Dockendorff was Executive Vice President and Chief Financial Officer of Covidien plc, a publicly traded medical device and supplies company, and its predecessor, Tyco Healthcare, from 1995 to 2015. Mr. Dockendorff joined the Kendall Healthcare Products Company, the foundation of the Tyco Healthcare business, in 1989 as Controller and was named Vice President and Controller in 1994. He was appointed Chief Financial Officer of Tyco Healthcare in 1995. Prior to joining Kendall/Tyco Healthcare, Mr. Dockendorff was the Chief Financial Officer, Vice President of Finance and Treasurer of Epsco Inc. and Infrared Industries, Inc.

Basic Compensation

Total Annual Compensation, USD 96,667
Restricted Stock Award, USD 184,976
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 281,643

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Michael Mahoney

13,084,500

Daniel Brennan

3,632,770

Kevin Ballinger

2,808,570

Joseph Fitzgerald

5,839,000

Edward Mackey

3,818,020

Ian Meredith

--
As Of  31 Dec 2017